Yun Lu1, Hui-Qin Qu1, Feng-Ying Chen2, Xiao-Ting Li3, Lan Cai2, Shan Chen1, Yuan-Yuan Sun1. 1. Department of Oncological Surgery, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, China. 2. Department of Nursing, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, China. 3. Department of Nursing, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, China, ksluyun@126.com.
Abstract
BACKGROUND:Cancer-related fatigue (CRF) is one of the most troubling symptoms of cancer patients during chemotherapy, and no gold standard for the treatment of CRF has been established. OBJECTIVE: This study aimed to examine the effects of the Baduanjin qigong on patients with colorectal cancer and CRF, and to explore its intervention effects. METHODS: This was an open-label, randomized controlled clinical trial. Ninety patients with chemotherapy-treated colorectal cancer and CRF were randomized to a Baduanjin exercise group or a routine care group. The primary outcome was the Brief Fatigue Inventory (BFI) score at 24 weeks. The secondary outcomes were the Karnofsky Performance Status (KPS) and Pittsburgh Sleep Quality Index (PSQI) scores at 24 weeks. RESULTS: There were no significant differences between the two groups in CRF level at baseline and 12 weeks. At 24 weeks, the proportion of patients with moderate-to-severe CRF was significantly smaller in the exercise group than in the control group (23.2 vs. 59.1%, p < 0.01). The KPS and PSQI scores were similar in the two groups at baseline and 12 weeks, but they were significantly higher and lower, respectively, at 24 weeks in the exercise group compared with the control group (KPS score: 89.3 ± 8.3 vs. 75.2 ± 11.5, p < 0.01; PSQI score: 4.1 ± 1.1 vs. 6.9 ± 2.0, p < 0.01). Significant time-group interactions were observed for all three scores (all p < 0.01). CONCLUSIONS:Baduanjin qigong exercise can relieve CRF in patients with colorectal cancer undergoing chemotherapy and can improve their physical activity level and their quality of sleep.
RCT Entities:
BACKGROUND:Cancer-related fatigue (CRF) is one of the most troubling symptoms of cancerpatients during chemotherapy, and no gold standard for the treatment of CRF has been established. OBJECTIVE: This study aimed to examine the effects of the Baduanjin qigong on patients with colorectal cancer and CRF, and to explore its intervention effects. METHODS: This was an open-label, randomized controlled clinical trial. Ninety patients with chemotherapy-treated colorectal cancer and CRF were randomized to a Baduanjin exercise group or a routine care group. The primary outcome was the Brief Fatigue Inventory (BFI) score at 24 weeks. The secondary outcomes were the Karnofsky Performance Status (KPS) and Pittsburgh Sleep Quality Index (PSQI) scores at 24 weeks. RESULTS: There were no significant differences between the two groups in CRF level at baseline and 12 weeks. At 24 weeks, the proportion of patients with moderate-to-severe CRF was significantly smaller in the exercise group than in the control group (23.2 vs. 59.1%, p < 0.01). The KPS and PSQI scores were similar in the two groups at baseline and 12 weeks, but they were significantly higher and lower, respectively, at 24 weeks in the exercise group compared with the control group (KPS score: 89.3 ± 8.3 vs. 75.2 ± 11.5, p < 0.01; PSQI score: 4.1 ± 1.1 vs. 6.9 ± 2.0, p < 0.01). Significant time-group interactions were observed for all three scores (all p < 0.01). CONCLUSIONS: Baduanjin qigong exercise can relieve CRF in patients with colorectal cancer undergoing chemotherapy and can improve their physical activity level and their quality of sleep.
Authors: Ann M Berger; Jean L Grem; Constance Visovsky; Heather A Marunda; Justin M Yurkovich Journal: Oncol Nurs Forum Date: 2010-11 Impact factor: 2.172
Authors: Pleun J de Raaf; Cora de Klerk; Reinier Timman; Jan J V Busschbach; Wendy H Oldenmenger; Carin C D van der Rijt Journal: J Clin Oncol Date: 2013-01-02 Impact factor: 44.544
Authors: Sandra A Mitchell; Susan L Beck; Linda Edwards Hood; Karen Moore; Ellen R Tanner Journal: Clin J Oncol Nurs Date: 2007-02 Impact factor: 1.027
Authors: Christina Andersen; Mikael Rørth; Bent Ejlertsen; Maria Stage; Tom Møller; Julie Midtgaard; Morten Quist; Kira Bloomquist; Lis Adamsen Journal: Eur J Oncol Nurs Date: 2012-10-16 Impact factor: 2.398
Authors: Anna Pyszora; Jacek Budzyński; Agnieszka Wójcik; Anna Prokop; Małgorzata Krajnik Journal: Support Care Cancer Date: 2017-05-16 Impact factor: 3.603
Authors: Pedro Machado; Miguel Morgado; João Raposo; Marco Mendes; Cândida G Silva; Nuno Morais Journal: Support Care Cancer Date: 2022-02-02 Impact factor: 3.603